ABVC BioPharma Strengthens Investment in AiBtl BioPharma with Equity Conversion and Future...
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced the conversion of a $100,000 convertible note into 10,000 shares of common stock in AiBtl BioPharma Inc. at a conversion price...